跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,168 条关于
“BEAM Alliance”
全部
3,168
临床试验
2,023
药物
73
机构
62
资讯
1,010
去年
MHRA Issues First UK Guidance for Phage Therapy Development to Combat Antibiotic-Resistant Infections
3个月前
AMR Bio Launches with Phase III-Ready Antimicrobial XF-73 to Combat Post-Surgical Infections
去年
Beam Therapeutics Receives FDA Orphan Drug Designation for BEAM-101 Sickle Cell Disease Therapy
去年
Beam Therapeutics Reports Breakthrough in Alpha-1 Antitrypsin Deficiency Treatment with BEAM-302 Base Editing Therapy
去年
Beam Therapeutics to Present Updated BEAM-101 Data from 17 Sickle Cell Disease Patients at EHA 2025
去年
Beam Therapeutics' BEAM-101 Shows Promise in Sickle Cell Disease Trial
3个月前
Beam Therapeutics Receives FDA Clearance for BEAM-304, a First-in-Class In Vivo Base Editing Therapy for Phenylketonuria
8个月前
Beam Therapeutics Secures FDA Accelerated Approval Pathway for BEAM-302 and Plans BLA Submission for Risto-cel by Year-End 2026
去年
Mercy Expands Cancer Treatment Options with Proton Beam Therapy Clinical Trials
去年
Beam Therapeutics Reports Patient Death in BEAM-101 Sickle Cell Disease Trial
第 1 页,共 101 页
上一页
下一页